---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-006083"
form_type: "8-K/A"
ticker: "DMAC"
cik: "0001401040"
company_name: "DiaMedica Therapeutics Inc."
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T05:19:54.277550+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# DiaMedica appoints Tanya N. Lewis to Board and Compensation Committee

## Summary
- Tanya N. Lewis appointed to DiaMedica Board effective March 1, 2023.
- Lewis appointed to Compensation Committee effective March 9, 2023.
- 8-K/A filed to disclose committee membership previously undetermined.
- No other changes from initial Form 8-K filed March 6, 2023.

## SEC filing metadata
- accession: 0001437749-23-006083
- form_type: 8-K/A
- ticker: DMAC
- cik: 0001401040
- company_name: DiaMedica Therapeutics Inc.
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401040/000143774923006083/0001437749-23-006083-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401040/000143774923006083/dmtp20230309_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-006083
- JSON: https://secwatch.observer/filing/0001437749-23-006083.json
- Plain text: https://secwatch.observer/filing/0001437749-23-006083.txt

## Key facts
- Executive change
  Tanya N. Lewis was appointed as Member of Compensation Committee at DiaMedica Therapeutics Inc..
  - Action: appointed
  - Role: Member of Compensation Committee
  source text: On and effective March 9, 2023, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed Ms. Lewis as a member of the Compensation Committee of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1401040/000143774923006083/0001437749-23-006083-index.htm
- Executive change
  Tanya N. Lewis was appointed as Director at DiaMedica Therapeutics Inc..
  - Action: appointed
  - Role: Director
  source text: the Board of Directors (the “Board”) of the Company appointed Tanya N. Lewis to the Board, effective March 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1401040/000143774923006083/0001437749-23-006083-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.